Journal Of Drug Targeting

Journal Of Drug Targeting

药物靶向杂志

  • 4区 中科院分区
  • Q1 JCR分区

期刊简介

《Journal Of Drug Targeting》是由Informa Healthcare出版社于1993年创办的英文国际期刊(ISSN: 1061-186X,E-ISSN: 1029-2330),该期刊长期致力于药学领域的创新研究,主要研究方向为医学-药学。作为SCIE收录期刊(JCR分区 Q1,中科院 4区),本刊采用OA未开放获取模式(OA占比0.0238...%),以发表药学领域等方向的原创性研究为核心(研究类文章占比44.93%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在69篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Journal Of Drug Targeting审稿周期约为 约2月 。该刊近年未被列入国际预警名单,年发文量约69篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 69 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 69 / 354

80.6%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 94 / 354

73.59%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:9.1 SJR:0.849 SNIP:0.706
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmaceutical Science Q1 23 / 183

87%

期刊发文

  • TGF beta 1/integrin beta 3 positive feedback loop contributes to acquired EGFR TKI resistance in EGFR-mutant lung cancer

    Author: Wang, Tao; Zhang, Yali; Cheng, Hanyue; Li, Ling; Xu, Lu

    Journal: JOURNAL OF DRUG TARGETING. 2023; Vol. 31, Issue 3, pp. 269-277. DOI: 10.1080/1061186X.2022.2064480

  • Macrophage membrane biomimetic drug delivery system: for inflammation targeted therapy

    Author: Zhang, Yulu; Long, Yu; Wan, Jinyan; Liu, Songyu; Shi, Ai; Li, Dan; Yu, Shuang; Li, Xiaoqiu; Wen, Jing; Deng, Jie; Ma, Yin; Li, Nan

    Journal: JOURNAL OF DRUG TARGETING. 2023; Vol. 31, Issue 3, pp. 229-242. DOI: 10.1080/1061186X.2022.2071426

  • Mucus- and pH-mediated controlled release of core-shell chitosan nanoparticles in the gastrointestinal tract for diabetes treatment

    Author: Shi, Yanan; Liu, Lanze; Yin, Miaomiao; Zhao, Zhenyu; Liang, Yanzi; Sun, Kaoxiang; Li, Youxin

    Journal: JOURNAL OF DRUG TARGETING. 2023; Vol. 31, Issue 1, pp. 65-73. DOI: 10.1080/1061186X.2022.2104296

  • Advances, challenge and prospects in cell-mediated nanodrug delivery for cancer therapy: a review

    Author: Wei, Wuhao; Zhang, Yuansheng; Lin, Zhizhe; Wu, Xin; Fan, Wei; Chen, Jianming

    Journal: JOURNAL OF DRUG TARGETING. 2023; Vol. 31, Issue 1, pp. 1-13. DOI: 10.1080/1061186X.2022.2104299

  • Poly-gamma-glutamic acid coating polymeric nanoparticles enhance renal drug distribution and cellular uptake for diabetic nephropathy therapy

    Author: Wang, Qili; Han, Shunping; Zhu, Yongqin; Wang, Guowei; Chen, Danfei

    Journal: JOURNAL OF DRUG TARGETING. 2023; Vol. 31, Issue 1, pp. 89-99. DOI: 10.1080/1061186X.2022.2106488

  • Nano-composite hydrogels of Cu-Apa micelles for anti-vasculogenic mimicry

    Author: Kang, Rui; Song, Mengdi; Fang, Zhou; Liu, Kehai

    Journal: JOURNAL OF DRUG TARGETING. 2023; Vol. 31, Issue 2, pp. 166-178. DOI: 10.1080/1061186X.2022.2115047

  • Progress in research and development of temozolomide brain-targeted preparations: a review

    Author: Yang, Jiefen; Xu, Youfa; Fu, Zhiqin; Chen, Jianming; Fan, Wei; Wu, Xin

    Journal: JOURNAL OF DRUG TARGETING. 2023; Vol. 31, Issue 2, pp. 119-133. DOI: 10.1080/1061186X.2022.2119243

  • Transdermal delivery of celecoxib and alpha-linolenic acid from microemulsion-incorporated dissolving microneedles for enhanced osteoarthritis therapy

    Author: Li, Jian; Tian, Xin; Wang, Kang; Jia, Yong; Ma, Fuguang

    Journal: JOURNAL OF DRUG TARGETING. 2023; Vol. 31, Issue 2, pp. 206-216. DOI: 10.1080/1061186X.2022.2123492